Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of HL151 vs Talion for Cutaneous Pruritus
KCT0003936Phase 3Recruiting
- Sponsor
- Hanlim Pharm
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Belion CR in pruritus, sponsored by Hanlim Pharm. Started May 2017; status: recruiting.
02
Drugs
Belion CR
03
Conditions
pruritus
Beyond the preview
Go deeper on KCT0003936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003936.